Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource  rightarrow Monoclonal Antibody Blog  rightarrow anti-DAF antibody  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
 • anti-BEC12 antibody blog
 • anti-Mbp antibody blog
 • anti-uPAR antibody blog
 • anti-Phosphotyrosine antibody blog
 • anti-CTNNb1 antibody blog
 • anti-IgG2c antibody blog
 • anti-GSTT2 antibody blog
 • anti-VEGF121 antibody blog
 • anti-E2F1 antibody blog
 • anti-GS antibody blog
 • anti-DSG2 antibody blog
 • anti-Troponin C-Cardiac antibody blog
 • anti-HIST1H2BB antibody blog
 • anti-CD31 antibody blog
 • anti-HDAC10 antibody blog
 • anti-CD8alpha/Lyt-2 antibody blog
 • anti-PLGF2 antibody blog
 • anti-TFPI antibody blog
 • anti-Kcnd3 antibody blog
 • anti-PINK1 antibody blog
Blog Categories separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
Our Best Sellers moreseparator
 • CD8a Antibody
 • NRIP1 Antibody
 • HLA-DRB (HLA-DRB1) Antibody
 • Cyclin B1 (CCNB1) Antibody
 • TM4SF1 Antibody
 • BCL2L1 - BCL-XL Antibody
 • CD70 antigen (CD70) Recombinant Protein
 • Matrix Metalloproteinase 13 (MMP-13) ELISA Kit
 • Interleukin-8 (IL8) Recombinant Protein
 • Filamin A, Alpha (FLNa) ELISA Kit
 • Thyroxine, T4 ELISA Kit
 • Enkephalin, Met (Penk) Antibody
 • Caspase-3 (CASP3) ELISA Kit
 downarrow more ...

anti-DAF antibody product blog

Posted on 2016-02-26 18:55:16 by mybiosource_staff
Share it on ...     
Tags: Antibody; Monoclonal Antibody; DAF; anti-DAF antibody;
The DAF n/a (Catalog #MBS584669) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The DAF, Human, mAb 1C6 reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s DAF can be used in a range of immunoassay formats including, but not limited to, Flow Ctometry (FC/FACS), Functional Studies (FS), Immuno Assay (IA), Western Blot (WB).
For flow cytometry and Western blotting, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user\'s experimental setting.. Researchers should empirically determine the suitability of the DAF n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:

The monoclonal antibody 1C6 recognizes human complement decay-accelerating factor (DAF), also designated as CD55. Cells express on their surface several proteins which protect against complement attack, namely complement receptor I (CR1), decay-accelerating factor (DAF), membrane cofactor protein (MCP) and CD59. CR1, DAF and MCP regulate the activation pathways of complement by either accelerating decay of the C3 and C5 convertase (CR1, DAF), or acting as cofactors for the serine protease factor I, which cleaves and irreversibly inactivates C3b (CR1, MCP).
Human DAF (CD55) is a protein of 381 amino acids resulting in a ~ 60 kDa transmembrane protein that binds C3b and C4b to inhibit formation and half-life of the C3 convertases. It belongs to the receptors of complement activation (RCA) family. DAF is broadly distributed among cells in contact with plasma complment proteins, including both haematopoietic and non-haematopoietic cells. Although DAF does not have an essential role in controling hemolysis of erythrocytes, it has an important role in regulation of the deposition of C3 on nucleated cells.
Together with other complement regulators DAF protects self cells from autologous complement-mediated injury. DAF cooperates with CD46 in circumventing autologous C3 deposition, while CD59 inhibits the pathway at the critical end-point. DAF is overexpressed in certain tumors thereby limiting the complement-dependent cytotoxiticy of therapeutic anticancer antibodies. Using DAF blocking antibodies targeted specifically at cancer cells in combination with immunotherapeutic monoclonal antibodies of cancer may improve the therapeutic effect in cancer patients. .

DAF n/a

Immunogen: Purified DAF from pooled human erythrocyte stroma. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing DAF are readily searchable from our website. Different antibodies against the same target such as DAF may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions